ImageVerifierCode 换一换
格式:PDF , 页数:320 ,大小:7.14MB ,
资源ID:789837      下载积分:10000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-789837.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(ISA AUTOMTN APPL BIO-PHARM-2008 Automation Applications in Bio-Pharmaceuticals.pdf)为本站会员(deputyduring120)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

ISA AUTOMTN APPL BIO-PHARM-2008 Automation Applications in Bio-Pharmaceuticals.pdf

1、AUTOMATION APPLICATIONS IN BIO-PHARMACEUTICALSBuckbee.book Page i Thursday, January 3, 2008 11:17 AMSeries page or blankBuckbee.book Page ii Thursday, January 3, 2008 11:17 AMAUTOMATION APPLICATIONS IN BIO-PHARMACEUTICALSBYGEORGE BUCKBEE, P.E.cm.Includes bibliographical references and index.ISBN 978

2、-1-934394-25-0 (softbound)1. Pharmaceutical biotechnology-Automation. I. Alford, Joseph, Ph.D. II. Title. DNLM: 1. Biopharmaceutics-methods. 2. Technology, Pharmaceutical.3. Drug Industry. QV 778 B922a 2008RS380.B83 2008615.190285dc222007049480Buckbee.book Page iv Thursday, January 3, 2008 11:17 AMv

3、CONTENTSPreface xiAcknowledgments xiiAbout the Authors xiiiList of Figures xivList of Tables xvii1 Introduction11.1 Overview 11.2 Factors Affecting Automation inBio-pharmaceuticals 1Biological Processes 2Government Regulations 3Good Engineering Practices 4Validation and Qualification Requirements 5S

4、anitary Design, CIP and SIP 6Containment 7Quality 7Procedures 8Personnel 8Vendor Management 91.3 How this Book Is Organized 10Chapter 2Hardware and Software 10Chapter 3Applications 10Chapter 4People, Projects, and Profitability 10Chapter 5Computer System Validation 11Chapter 6Batch Control 12Chapter

5、 7Advanced Automation Techniques 12Appendices 12What is NOT Covered in this Book 122 Hardware and Software152.1 General Hardware Design Considerations 15Sanitary Design Considerations 15Materials 16Surface Finish 16Drainability 18Maintainability 18Buckbee.book Page v Thursday, January 3, 2008 11:17

6、AMvi Contents2.2 Valves 18Diaphragm Valves 18Actuators and Feedback Devices 20Multi-port Valve Clusters 21Ball Valves 22Regulating Valves 222.3 Transfer Panels 252.4 Bioprocess Measurement: Instrumentation 26General Considerations for Instrumentation 26Calibration 27Temperature 28Level and Weight 29

7、Flow 30pH Measurement 30Dissolved Oxygen 33Process Analytical Technology 342.5 Computer Equipment 352.6 Controllers, Chart Recorders, Other 36Single-Loop Controller 36System Architecture Design 36DCS 47HMIs 482.7 Process Information Management 49Data Storage Considerations 49Chart Recorders 50Electr

8、onic Data Historians 50Alarm Logging and Alarm Management 52Performance Supervision 52Statistical Process Control 53Reporting 54Maintenance Systems 552.8 Software Design 56Good Automation Manufacturing Practices (GAMP) 56Modular Designs 56Modular Software 58Skid Integration 58Historization and Repor

9、ting 65Batch Control Software 663 Applications 733.1 Automation Applications in Bio-pharmaceuticals 73Process Description and Challenges 73Typical Instrumentation Requirements 73Buckbee.book Page vi Thursday, January 3, 2008 11:17 AMContents viiControl Strategies 73How Much Automation Do You Need? 7

10、53.2 Utility Applications 763.3 Clean-In-Place: CIP 76Process Description and Challenges 76Typical CIP Instrumentation Requirements 77Control Strategies for CIP 803.4 Steam-In-Place: SIP 82SIP Process Description and Challenges 82Typical Instrumentation Requirements 82Control Strategies for SIP 843.

11、5 Water-for-Injection: WFI 87Process Description and Challenges 87Typical Instrumentation Requirements 873.6 Clean Steam 91Process Description and Challenges 91Typical Instrumentation Requirements 91Control Strategies 913.7 Clean Compressed Air 92Process Description and Challenges 92Typical Instrume

12、ntation Requirements 93Control Strategies 933.8 Formulation 94Process Description and Challenges 94Typical Instrumentation Requirements 95Control Strategies 953.9 HVAC 97Process Description and Challenges 97Communications 98Typical Instrumentation Requirements 98Control Strategies 983.10 Bioreactors

13、 99Process Description and Challenges 99Typical Instrumentation Requirements 100Control Strategies 1023.11 Bioprocess Filtration 108Process Description and Challenges 108Typical Instrumentation Requirements 108Control Strategies 1083.12 Precipitation 112Process Description and Challenges 112Buckbee.

14、book Page vii Thursday, January 3, 2008 11:17 AMviii ContentsTypical Instrumentation Requirements 113Control Strategies 1133.13 Centrifugation 116Process Description and Challenges 116Typical Instrumentation Requirements 116Control Strategies 1183.14 Waste Containment and Processing Systems 119Proce

15、ss Description and Challenges 119Typical Instrumentation Requirements 120Control Strategies 1203.15 Controlled Temperature Environments 122Process Description and Challenges 122Typical Instrumentation Requirements 1224 People, Projects, and Profitability1254.1 People 126Engineering 127Process Defini

16、tion Personnel 138Validation Personnel 142Quality 147Information Systems/Information Technology 150Operations 155Maintenance 1574.2 Projects 161Getting Organized 161Schedule 162Budget 163Managing Automation Resources 165Reducing the Cost of Automation Projects 1654.3 Profitability 168Value Engineeri

17、ngChoices to Reduce Cost 170Project Cost versus Life Cycle Cost 171Reducing Batch Cycle Time 172Improving Product Quality 176Reducing Operating Costs 179Ensuring Optimal Performance 1815 Computer System Validation 1835.1 Introduction 183Overview 183Validation Master Plan 185Computer Systems 186Buckb

18、ee.book Page viii Thursday, January 3, 2008 11:17 AMContents ix5.2 Historical Perspective 188The FDA and PMA 188Validation Life Cycle Diagram 1895.3 Computer Validation General Considerations 190Validation Master Plan 190Standard Operating Procedures 190Electronic Records and Electronic Signatures 1

19、935.4 Designing and Building Quality into the System 195Functional (User and System) Requirements 195Design 196Source Code Review 199Vendor Audits 200Testing 202User Acceptance 2055.5 Operating the System 205SOPs 205Training 205Monitoring the System 2065.6 Ensuring the System Stays in a State of Val

20、idation 207General 207Maintenance 207Contingency Planning 208Security 209Periodic Review 210Change Control 212Automated Audit Trails 2176 Batch Processing.2216.1 Introduction: “To Batch or Not to Batch” 2216.2 Upstream “Inter-Unit” Operations 2256.3 Upstream “Intra-Unit” Operations 2296.4 Downstream

21、 “Inter-Unit” Operations 2336.5 Downstream “Intra-Unit” Operations 2376.6 ISA-88.01 Batch Standard 2416.7 Use and Value of Batch Sequencing/Management Software 2466.8 Use and Value of Batch Historians 2506.9 Discrete Event Modeling 254Buckbee.book Page ix Thursday, January 3, 2008 11:17 AMx Contents

22、7 Advanced Techniques2597.1 Bioprocess Measurement 259PAT (Process Analytical Technology) 259Process Mass Spectrometry 260On-line HPLC 262Other Examples of PAT Sensors 262Online Estimators (i.e., Virtual Sensors) 2637.2 Dynamic Modeling 268Fermentation Models 2687.3 Advanced Control Techniques 273Ne

23、ural Networks 273Fuzzy Logic 279Model Predictive Control 281Adaptive Control 285Process Performance Supervision and Control System Asset Management 288Glossary 293Index 297ch00b_TOC.fm Page x Thursday, January 3, 2008 1:59 PMxiPREFACEThe bio-pharmaceutical industry demands exacting detail in design,

24、 devel-opment, operation, quality, and just about every other aspect of the busi-ness. As such, there is a degree of specialty in most every field of endeavorin this industry. This book was developed to try to accelerate the learningprocess for the application of automation in bio-pharmaceuticals. T

25、heauthors hope is that the content of this book will help scientists and engi-neers continue to contribute to the manufacture of high-quality medicinesvia improving process control and on-line availability of informationwhile reducing costs, cycle time, and process variability. Some readers may come

26、 into this industry with previous automationexperience. Others may be in the bio-pharmaceutical industry, but havelimited automation knowledge. In either case, the authors strived to bringthe reader to a more thorough understanding of the topics. This book is supplemented by a wealth of reference ma

27、terials in the indus-try. Each chapter contains a list of recommended reference materials.Buckbee.book Page xi Thursday, January 3, 2008 11:17 AMxiiACKNOWLEDGMENTSThe authors would like to acknowledge the individuals and organizationswho helped to make this book possible. Susan Colwell and the staff

28、 at ISAprovided excellent, concise, and professional guidance. Greg McMillanhelped conceive of the book, and provided detailed and thoughtfulreview. Gregs colleague at Emerson Process, Terry Blevins, also providedexcellent review of materials. John Gerry at ExperTune lent us his decadesof experience

29、 in control loop performance metrics. The authors alsothank Eli Lillys Dr. Jeff Baker for his input regarding process validation,Ben Paterson regarding content on downstream bioprocess unit opera-tions, and Dave Dzirbik for content regarding the automation of down-stream bioprocess unit operations.

30、We owe a debt of gratitude to thosewho have gone before us in developing the literature on topics related tobio-pharmaceuticals and automation. We also owe many thanks to thecontributions of our colleagues who, during our careers, provided techni-cal input, insights, support, and challenging questio

31、ns. The authors would like to recognize the special role of the Pharmaceuti-cal/Biotech industries for providing an environment where employees cancome to work and develop and manufacture medicines that make a differ-ence in the quality of life of their customers. Additionally, the authorswould like

32、 to thank the management of their employers (Expertune andLilly) for providing the opportunity and encouragement to evaluate newautomation technologies, develop applications, and share automationknowledge with others. Finally, we extend a very special thank you to our families and dedicatethis book

33、to them. What started as a small project grew quickly into a sec-ond job. Our families have done without us for hours on end as weworked to finalize the materials in this book. To Mary Ellen Buckbee, yourwisdom and understanding are boundless. Alyssa, Brendan, and CameronBuckbee, thanks for being so

34、 patient with this process. To Marti Alford,your support and encouragement throughout your husbands career hasbeen invaluable and greatly appreciated. Buckbee.book Page xii Thursday, January 3, 2008 11:17 AMxiiiABOUT THE AUTHORSGeorge Buckbee, P.E. is a process control industry veteran. George holds

35、 aB.S. in Chemical Engineering from Washington University in St. Louis,and an M.S. in Chemical Engineering from the University of California atSanta Barbara. George has 17 years of direct industry experience, atProcter computer and network under-standing; and the abilities to read, write, and review

36、 engineering draw-ings. Internal competencies include understanding of the particularprocess being controlled, as well as training in company-specific or site-specific procedures. Both internal and external competencies must beaddressed and documented.Chapter 4, “People, Projects, and Profitability,

37、” addresses key issues in theselection and qualification of personnel for automation work.Vendor ManagementIt is very typical for an automation project to employ many different ven-dors to handle design, construction, commissioning, qualification, andmaintenance of the automation system.To ensure th

38、e quality of the automation system design, companies mustemploy qualified vendors. A proper vendor evaluation program, coupledwith direct oversight of all contracted deliverables and services, is vital toa high-quality outcome.The first step in ensuring a quality result with any vendor is to have ac

39、learly-defined scope. Scope definition is addressed in the “ManagingAutomation Projects” section in Chapter 4.Industry groups are a valuable resource for establishing docu-mentation of external competencies. For example, the ISA “Cer-tified Automation Professional” program and the “Certified Control

40、 System Technician” program provide a solid measure of assur-ance and documentation that personnel are qualified. ISPE also offers courses in the application of GAMP. 1.7, 1.8Buckbee.book Page 9 Thursday, January 3, 2008 10:49 AM10 Chapter 1Introduction1.3 How this Book Is OrganizedChapter 2Hardware

41、 and SoftwareChapter 2 focuses on design criteria for hardware and software in the bio-pharmaceutical industry. The focus is on the most commonly used sys-tems in bio-pharmaceuticals.The first part of the chapter focuses on hardware, including valves, instru-mentation, and transfer panels. We discus

42、s the key design and implemen-tation considerations for each of these devices.The second half of this chapter discusses software design considerations,including Good Automated Manufacturing Practices (GAMP), ModularDesign, Skid Integration, and System Security.Chapter 3ApplicationsChapter 3 provides

43、 a great deal of information on the design of automa-tion systems for the most common processes. For each process, wedescribe:Process Description and ChallengesInstrumentationControl StrategiesThe engineer must develop a solid understanding of the process beingcontrolled to effectively design the au

44、tomation system. The goal of thischapter is to provide a basis for understanding some of the most commonprocesses in bio-pharmaceuticals.Chapter 4People, Projects, and ProfitabilityChapter 4 provides guidance on some of the “soft” issues affecting auto-mation system implementation. It is crucial for

45、 the engineer to under-stand that an excellent design, if poorly implemented, will result infailure. To ensure success, we must consider the critical “soft” issues. Thechapter is divided into three sections: People, Projects, and Profitability.Buckbee.book Page 10 Thursday, January 3, 2008 10:49 AMH

46、ow this Book Is Organized 11In the “People” section we discuss the impact of process automation:Roles and ResponsibilitiesTrainingQualificationsIn the “Projects” section we discuss the most important procedural issuesfor automation, including:Scope Definition and Scope ControlChange ControlVendor Se

47、lection and Commercial IssuesIn the “Profitability” section we discuss some of the financial consider-ations of automation system design. This includes discussion of the fol-lowing topics:Project ManagementVendor ManagementBalancing Quality, Cost, and ScheduleValue Engineering for AutomationAutomati

48、on may be a relatively new technology in some plants. The goalof Chapter 4 is to identify key adaptations that may be required for theorganization to implement and support automation.Chapter 5Computer System ValidationProcesses used in the manufacture of pharmaceuticals for human con-sumption must b

49、e validated. The scope of validation includes not onlythe chemical processing unit operations themselves but also supportingaspects of manufacturing operations such as assay validation, cleaningvalidation, utility validation (e.g., use of purified water), and computervalidation. Chapter 5 summarizes validation requirements for computersystems.Buckbee.book Page 11 Thursday, January 3, 2008 10:49 AM12 Chapter 1IntroductionChapter 6Batch ControlMany bioprocesses are batch in nature, rather than continuous processes.Automation of batch systems brings some special challeng

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1